Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-036881
Filing Date
2024-08-13
Accepted
2024-08-13 11:52:08
Documents
94
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K valn-20240630.htm   iXBRL 6-K 997437
2 EX-99.1 h12024resultspressrelease.htm EX-99.1 114687
8 valn-20240630_g1.jpg GRAPHIC 329905
9 valn-20240630_g2.jpg GRAPHIC 94442
10 valn-20240630_g3.jpg GRAPHIC 314010
  Complete submission text file 0001628280-24-036881.txt   7434222

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT valn-20240630.xsd EX-101.SCH 81393
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT valn-20240630_cal.xml EX-101.CAL 100448
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT valn-20240630_def.xml EX-101.DEF 179080
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT valn-20240630_lab.xml EX-101.LAB 534951
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT valn-20240630_pre.xml EX-101.PRE 387510
96 EXTRACTED XBRL INSTANCE DOCUMENT valn-20240630_htm.xml XML 826598
Mailing Address 6, RUE ALAIN BOMBARD SAINT-HERBLAIN I0 44800
Business Address 6, RUE ALAIN BOMBARD SAINT-HERBLAIN I0 44800 33 2 28 07 37 10
Valneva SE (Filer) CIK: 0001836564 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40377 | Film No.: 241199783
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)